BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 3763679)

  • 1. Methods for estimating drug bioavailability parameters. Part 2: Methods for estimating absorption rate.
    Firsov AA; Piotrovskii VK
    Pharmazie; 1986 Jun; 41(6):369-77. PubMed ID: 3763679
    [No Abstract]   [Full Text] [Related]  

  • 2. Methods for estimating drug bioavailability parameters. Part 1: Concept of biological availability and methods for estimating the extent of systemic absorption.
    Firsov AA; Piotrovskii VK
    Pharmazie; 1986 May; 41(5):313-9. PubMed ID: 3737660
    [No Abstract]   [Full Text] [Related]  

  • 3. Methods for estimating drug bioavailability parameters. Part 3: Peculiarities of pharmacokinetic analysis in assessment of bioavailability.
    Firsov AA; Piotrovskii VK
    Pharmazie; 1986 Jul; 41(7):457-65. PubMed ID: 3534896
    [No Abstract]   [Full Text] [Related]  

  • 4. An APL computer program for estimating rate constants of drug absorption.
    Zeng YL; Akkermans AA; van Waning WE; Breimer DD
    Arzneimittelforschung; 1983; 33(6):902-4. PubMed ID: 6688530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimating drug solubility in the gastrointestinal tract.
    Dressman JB; Vertzoni M; Goumas K; Reppas C
    Adv Drug Deliv Rev; 2007 Jul; 59(7):591-602. PubMed ID: 17599644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Calculation of different pharmacokinetic parameters from plasma data for a bicompartmental model of first order oral absorption].
    Fredj G; Clenet M; Rousselet F
    Therapie; 1978; 33(1):133-6. PubMed ID: 663893
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of nutrition on drug bioavailability].
    Boutin-Pannetier MS; Delhotal-Landes B; Flouvat B
    Therapie; 1986; 41(5):397-402. PubMed ID: 3544322
    [No Abstract]   [Full Text] [Related]  

  • 8. [First-pass effect as a therapeutic problem].
    Danek A
    Pol Tyg Lek; 1983 Apr; 38(16):511-4. PubMed ID: 6634498
    [No Abstract]   [Full Text] [Related]  

  • 9. Intestinal drug absorption and bioavailability: beyond involvement of single transport function.
    Lennernäs H
    J Pharm Pharmacol; 2003 Apr; 55(4):429-33. PubMed ID: 12803763
    [No Abstract]   [Full Text] [Related]  

  • 10. Gastrointestinal absorption II. Formulation factors affecting drug bioavailability.
    Blanchard J
    Am J Pharm Sci Support Public Health; 1978; 150(5):132-51. PubMed ID: 364993
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetic aspects relevant to biopharmaceutics].
    Segre G
    Ann Ist Super Sanita; 1982; 18(3):533-40. PubMed ID: 7187841
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on absorption and elimination of drugs. Part VII. Fitting of a three exponential equation to the observed drug concentration data after single extravascular administration.
    Danek A; Kajzar F; Zieba A
    Int J Clin Pharmacol Biopharm; 1978 Feb; 16(2):86-94. PubMed ID: 631975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors affecting the error in the Loo-Riegelman method for estimating the rate of drug absorption. Some suggestions for a practical sampling schedule.
    Zeng YL; Akkermans AA; Breimer DD
    Arzneimittelforschung; 1983; 33(5):757-60. PubMed ID: 6688184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating human drug oral absorption kinetics from Caco-2 permeability using an absorption-disposition model: model development and evaluation and derivation of analytical solutions for k(a) and F(a).
    Usansky HH; Sinko PJ
    J Pharmacol Exp Ther; 2005 Jul; 314(1):391-9. PubMed ID: 15833900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and bioavailability.
    Wagner JG
    Triangle; 1975; 14(3-4):101-8. PubMed ID: 1209729
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effects of drug distribution, entero-hepatic cycle, bioavailability].
    Bailly-Salins F; Woronoff-Lemsi MC
    Soins; 1998 Apr; (624):41-3. PubMed ID: 9633463
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pharmacokinetic methods for the evaluation of intestinal absorption].
    Kübler W
    Z Kinderheilkd; 1970; 108(3):187-96. PubMed ID: 5475029
    [No Abstract]   [Full Text] [Related]  

  • 18. Relevance, experiences, and trends in the use of compartmental models.
    Segre G
    Drug Metab Rev; 1984; 15(1-2):7-53. PubMed ID: 6378563
    [No Abstract]   [Full Text] [Related]  

  • 19. What is bioavailability? Philosophy of bioavailability testing.
    Ritschel WA
    Methods Find Exp Clin Pharmacol; 1984 Dec; 6(12):777-86. PubMed ID: 6530912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Food intake and drug bioavailability.
    Melander A
    Prog Clin Biol Res; 1981; 77():747-56. PubMed ID: 6121332
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.